Medical Devices Startups

Access TeleCare provides a telemedicine platform and cart hardware that connects hospitals and their patients with remote specialists for acute specialty care and behavioral health. Founded by physicians, it designs custom virtual care delivery programs for hospitals along with 24/7 U.S.-based technical support.

1 investor

Access2Bone develops bone graft products containing human tissue-based compositions for orthopedic surgeries. The company's offerings are designed for foot, ankle, and spine fusion procedures.

1 investor

Accession Therapeutics develops cancer treatments by harnessing immune system mechanisms, with a focus on T cell receptor therapies and engineered cell therapies. The company is led by experienced biotech entrepreneurs and scientific experts with a track record in bringing immunological oncology projects to clinical development.

1 investor

Acclaro develops UltraClear, an aesthetic laser platform using proprietary 2910 nm cold ablative fiber laser technology with seven treatment modules in one device for skin rejuvenation, addressing photodamage, wrinkles, acne scars, pigmentation, and laser-enabled surgical procedures. The device is sold to physicians and aesthetic practices for treating patients across all skin types.

1 investor

Accunea develops organ condition monitoring technology that tracks biomarkers of kidney function and metabolism before and after transplantation, providing clinicians with continuous point-of-care data and AI-driven trend analysis. It serves transplant centres and clinicians to assess organ viability and support patient recovery, and integrates with hospital EPR systems.

1 investor

Accuryn develops a monitoring system for detecting acute kidney injury and catheter-associated urinary tract infections in hospitalized patients, particularly in critical care settings.

1 investor

ACEA Therapeutics is a clinical-stage pharmaceutical company developing small molecule inhibitors, antibody drug conjugates, and cell therapies to address unmet needs in cancer, autoimmune disease, and COVID-19. The company operates manufacturing and commercial capabilities in China and has multiple candidates in clinical development.

1 investor

Acepodia develops cell therapies for cancer treatment, leveraging proprietary immune cell engineering and tumor-targeting technology to create off-the-shelf therapeutic options for broad patient populations.

1 investor

Actinia develops radiation detector materials based on CsPbBr3 (perovskite) semiconductors to improve the resolution and reduce the dose of radiological imaging techniques such as SPECT, CT, and X-ray, with applications in medicine and security. The company commercializes technology first developed at Northwestern University.

1 investor

Actipulse Neuroscience develops non-invasive brain stimulation technologies using high-frequency magnetic pulses to treat central nervous system disorders, including major depressive disorder and neurodegenerative diseases. The company conducts clinical research on transcranial neuromodulation devices.

1 investor

A dental implant restoration provider offering single-tooth and full-arch prosthetic solutions for patients seeking functional and aesthetic implant replacements.

1 investor

ActiveProtective is the maker of the Tango Belt, a wearable device product.

1 investor

AcuamarkDx is a molecular diagnostics company developing early cancer detection technology using proprietary qPCR and machine learning-driven assays for cancer screening and recurrence monitoring. It aims to make frequent, recurring cancer signal monitoring a standard part of primary care.

1 investor

Kubota Vision develops pharmaceutical drugs and medical devices to preserve and restore vision for patients with eye diseases worldwide. The company is a subsidiary of Kubota Pharmaceutical and focuses on treating blindness.

1 investor

Acumen Sports and Shoulder provides orthopedic surgical care and sports medicine services, including injury assessment, rehabilitation, and performance training for athletes. The company serves competitive and recreational athletes through certified athletic therapists and surgeons specializing in musculoskeletal injury management.

1 investor

Acumen Pharmaceuticals is developing treatments for Alzheimer's disease and other neurodegenerative diseases, focusing on understanding and targeting amyloid beta oligomers in neurodegeneration.

1 investor

Adalid Sciences engineers lipid nanoparticles to improve the delivery and efficacy of gene therapies, targeting better therapeutic outcomes with reduced side effects. The company serves developers of nucleic acid medicines and therapeutic partners seeking advanced drug delivery solutions.

1 investor

Adapta Medical makes the PerfIC Cath, a sterile touchless intermittent catheter and urine collection bag designed with features such as large finger loops, a securing hook, and an expanded sheath diameter for individuals with limited or normal dexterity. The product targets patients with conditions like spinal cord injury, multiple sclerosis, diabetes, stroke, or spina bifida who need to catheterize, and serves patients, caregivers, and healthcare professionals.

1 investor

Adare Pharma Solutions is a CDMO (contract development and manufacturing organization) and pharma services provider serving the biopharma industry with manufacturing, research and development, and patient support capabilities.

1 investor

Adcendo develops antibody-drug conjugates (ADCs) engineered to treat cancers with high unmet medical needs. The company translates scientific innovation into clinically differentiated medicines for patients with advanced solid tumors and other cancer types.

1 investor

Addon Optics develops a technology platform that automates and optimizes the manufacturing and distribution of ophthalmic lenses for optical labs, retailers, and distributors. The platform aims to reduce production costs, capital requirements, and labor while accelerating production speed.

1 investor

Addimmune develops gene therapy treatments for HIV, specifically AGT103-T, a first-in-class functional cure candidate that modifies patient immune cells to recognize and eliminate HIV-infected cells. The company is based in Rockville, Maryland and targets individuals living with HIV.

1 investor

AdEchoTech develops MELODY, a patented tele-operated robotic ultrasound system that lets a physician perform real-time ultrasound examinations remotely while keeping full control of the medical gesture and scanner settings. It serves hospitals, medical deserts, prisons, nursing homes (EHPAD), and independent physicians to improve access to expert diagnostic imaging.

1 investor

Adenocyte develops LINFU (Low Intensity Non-Focused Ultrasound), a minimally invasive ultrasound technology for routine screening of the pancreas to detect pancreatic dysplasia and early-stage pancreatic cancer. The company serves clinical cancer screening for elevated- and average-risk patients, with laboratories in Haifa and Jerusalem and clinical development at the Technion and North American screening centers.

1 investor